Pulmonary Langerhans Cell Histiocytosis in the Elderly Smoker

被引:0
|
作者
Jeelani, Hafiz Muhammad [1 ]
Ehsan, Hamid [2 ,3 ]
Sheikh, Muhammad Mubbashir [4 ]
Riaz, Adeel [5 ]
Mahboob, Hafiz [6 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Internal Med, Mchenry, IL USA
[2] MedStar Union Mem Hosp, Internal Med, Baltimore, MD USA
[3] Georgetown Univ, Biomed Sci Biohazardous Threat Agents & Emerging, Washington, DC USA
[4] Northwestern Univ, Feinberg Sch Med, Oncol, Chicago, IL 60611 USA
[5] Dist Headquarter Hosp, Anesthesiol & Crit Care, Sahiwal, Pakistan
[6] Univ Nevada, Las Vegas Sch Med, Pulm & Crit Care Med, Las Vegas, NV 89154 USA
关键词
plch; lch; smoking; cd1a;
D O I
10.7759/cureus.10377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Langerhans cell histiocytosis (LCH), formally referred to histiocytosis X, is a histiocytic disorder with unknown etiology. The pathogenesis is believed to originate from myeloid dendritic cells and is now considered an inflammatory myeloid neoplasm within the revised 2016 Histiocyte Society classification. Pulmonary Langerhans cell histiocytosis (PLCH) is a rare and isolated form of LCH with a strong affiliation with smoking in adults of 20-40 years of age. Characteristic CT chest and histologic findings are instrumental in the early recognition and management of a disease. We herein report a case of a Caucasian smoker female with a significant history of interstitial lung disease (ILD) presented with recurrent and progressive worsening dyspnea. History of ILD and recurring respiratory symptoms raised suspicion of PLCH. CT chest and pathological findings confirmed the diagnosis, and discontinuation of smoking resulted in favorable clinical outcomes.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Pulmonary Langerhans Cell Histiocytosis
    Shaw, Brian
    Borchers, Michael
    Zander, Dani
    Gupta, Nishant
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (02) : 269 - 279
  • [2] Pulmonary Langerhans cell histiocytosis - an update on pathogenesis and treatment
    Jouenne, Fanelie
    Benattia, Amira
    Tazi, Abdellatif
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 451 - 458
  • [3] Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis
    E. Radzikowska
    K. Błasińska–Przerwa
    E. Wiatr
    I. Bestry
    R. Langfort
    K. Roszkowski-Śliż
    Lung, 2018, 196 : 715 - 720
  • [4] Pulmonary Amyloidosis in a Patient With Langerhans Cell Histiocytosis
    Mukherjee, Anirban
    Dhull, Varun Singh
    Sharma, Punit
    Parida, Girish Kumar
    Jain, Sachin
    Pal, Lily
    Kumar, Rakesh
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (04) : E263 - E264
  • [5] Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis
    Radzikowska, E.
    Blasinska-Przerwa, K.
    Wiatr, E.
    Bestry, I.
    Langfort, R.
    Roszkowski-Sliz, K.
    LUNG, 2018, 196 (06) : 715 - 720
  • [6] Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
    Grobost, Vincent
    Khouatra, Chahera
    Lazor, Romain
    Cordier, Jean-Francois
    Cottin, Vincent
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 191
  • [7] A unique presentation of Pulmonary Langerhans Cell Histiocytosis
    Srivatsav, Varun
    Tallon, Kelsey
    RESPIRATORY MEDICINE CASE REPORTS, 2022, 37
  • [8] Pulmonary Langerhans Cell Histiocytosis Masquerading as Lymphangioleiomyomatosis
    Patel, Priya
    Anamika, F. N. U.
    Ali, Rana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [9] Bronchoalveolar lavage for the diagnosis of Pulmonary Langerhans cell histiocytosis
    Lommatzsch, Marek
    Bratke, Kai
    Stoll, Paul
    Muelleneisen, Norbert
    Prall, Friedrich
    Bier, Andrea
    Virchow, J. Christian
    RESPIRATORY MEDICINE, 2016, 119 : 168 - 174
  • [10] Pulmonary Langerhans cell histiocytosis; characteristics of 11 cases
    Aydogdu, Koray
    Gunay, Ersin
    Findik, Gokturk
    Gunay, Sibel
    Agackiran, Yetkin
    Kaya, Sadi
    Karaoglanoglu, Nurettin
    Tastepe, Irfan
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2013, 61 (04): : 333 - 341